CEL-SCI Corporation has announced plans to issue shares of its common stock through an underwritten public offering. The purpose behind this initiative is to channel the raised funds towards the ongoing development of its Multikine project as well as other general corporate activities. ThinkEquity will take on the role of the sole book-running manager for the offering. This move is part of CEL-SCI's strategic efforts to bolster its financial resources for key business and research objectives.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for CEL-SCI Corp (CVM, Financial) is $222.00 with a high estimate of $300.00 and a low estimate of $180.00. The average target implies an upside of 4,822.39% from the current price of $4.51. More detailed estimate data can be found on the CEL-SCI Corp (CVM) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, CEL-SCI Corp's (CVM, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
